Warburg Pincus LLC and Mubadala Investment Company PJSC signed a binding agreement to acquire 85% stake in Pharma Intelligence from Informa plc (LSE:INF) for £1.7 billion on February 10, 2022. Informa will retain 15% ownership in Pharma Intelligence. Pharma Intelligence reported gross assets of £479.9 million as at June 30, 2021.

The acquisition is expected to complete in early June 2022, subject to any relevant regulatory clearances. The deal is subject to Informa plc (LSE:INF) board approval. As of February 10, 2022 Informa plc (LSE:INF) board approved the deal.

BofA Securities acted as financial advisor to Informa. Centerview Partners acted as financial advisor to Informa plc. Steven Fox, Erik O'Connor, André Duminy, Nicola Hemsley, Stephen Reese, Nelson Jung, Benjamin Sibbett, Reuben van Werkum, Julia House, Paul Koppel of Clifford Chance LLP acted as legal advisor to Informa plc in the transaction.

Adrian Maguire, Dan Clarke, Keir MacLennan; Keri Schick Norton, Neel V. Sachdev, Eric J. Wedel, P.C., Ben Steadman, Stefan Arnold-Soulby, Peter Abbott, Sam Trowbridge, Paula Riedel, Matthew Sinclair-Thomson and Jenny Wilson of Kirkland & Ellis and Peter Myners and Victoria Woestmann of Allen & Overy Luxembourg acted as legal advisors to Warburg Pincus.